Page 5,024«..1020..5,0235,0245,0255,026..5,0305,040..»

Ray, Erik, Dustin,

Posted: Published on July 26th, 2013

Ray, Erik, Dustin, Matthew - High School Stem Cell Research Interns - Summer 2013 Ray Solis is a High Tech High North County student, Erik Owen is a Westview High School student, Dustin Nguyen is a Crawford High School student and Matthew ... By: California Institute for Regenerative Medicine … Continue reading →

Posted in Stem Cell Research | Comments Off on Ray, Erik, Dustin,

Fyezah Nazir – High School Stem Cell Research Intern – Summer 2013 – Video

Posted: Published on July 26th, 2013

Fyezah Nazir - High School Stem Cell Research Intern - Summer 2013 Fyezah Nazir is a Mira Mesa High School student who is doing a stem cell research internship this summer in the laboratory of Brunie Felding-Habermann at The... By: California Institute for Regenerative Medicine … Continue reading →

Posted in Stem Cell Research | Comments Off on Fyezah Nazir – High School Stem Cell Research Intern – Summer 2013 – Video

Sir Terry Matthews helps launch new strategy to battle cancer

Posted: Published on July 26th, 2013

25 Jul 2013 22:07 Patron Sir Terry champions efforts of European Cancer Stem Cell Research Institute to develop new treatments for cancers Newport billionaire Sir Terry Matthews tonight helped unveil a new cancer-fighting strategy which could lead to the development of new treatments and improve the prognosis for patients. The European Cancer Stem Cell Research Institute (ECSCRI) at Cardiff University is investigating the way cancer stem cells are analysed and interpreted. The Institutes director, Professor Alan Clarke, shared the teams latest findings with luminaries from across the world at the Targeting Cancer Conference at Newports Celtic Manor Resort this week. As the Institutes patron, telecoms tycoon Sir Terry has helped offer a different view through his network and contacts. Sir Terry said: The impact of Professor Alan Clarke and his teams cancer research has implications way beyond the UK with potential to be world-leading and a huge gain to humanity. I wholeheartedly champion its efforts to develop new treatments across a broad range of cancers. The owner of the Celtic Manor spoke about his interest in cancer research which started after the death of his mother from ovarian cancer. I got to know a few of the specialists and Id … Continue reading →

Posted in Stem Cell Research | Comments Off on Sir Terry Matthews helps launch new strategy to battle cancer

'Epilepsy in a dish': Stem cell research reveals clues to disease's origins and may aid search for better drugs

Posted: Published on July 26th, 2013

July 25, 2013 A new stem cell-based approach to studying epilepsy has yielded a surprising discovery about what causes one form of the disease, and may help in the search for better medicines to treat all kinds of seizure disorders. The findings, reported by a team of scientists from the University of Michigan Medical School and colleagues, use a technique that could be called "epilepsy in a dish." By turning skin cells of epilepsy patients into stem cells, and then turning those stem cells into neurons, or brain nerve cells, the team created a miniature testing ground for epilepsy. They could even measure the signals that the cells were sending to one another, through tiny portals called sodium channels. In neurons derived from the cells of children who have a severe, rare genetic form of epilepsy called Dravet syndrome, the researchers report abnormally high levels of sodium current activity. They saw spontaneous bursts of communication and "hyperexcitability" that could potentially set off seizures. Neurons made from the skin cells of people without epilepsy showed none of this abnormal activity. They report their results online in the Annals of Neurology, and have further work in progress to create induced pluripotent stem … Continue reading →

Posted in Stem Cell Research | Comments Off on 'Epilepsy in a dish': Stem cell research reveals clues to disease's origins and may aid search for better drugs

Stem Cell Therapeutics Provides Corporate Update

Posted: Published on July 26th, 2013

TORONTO, ONTARIO--(Marketwired - Jul 25, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(SCTPF), a biopharmaceutical company developing cancer stem cell-related therapeutics, today provided the following corporate update: About Stem Cell Therapeutics: Stem Cell Therapeutics Corp. (SCT) is a biopharmaceutical company dedicated to advancing cancer stem cell discoveries into novel and innovative cancer therapies. Building on over half a century of leading and groundbreaking Canadian stem cell research, the company is supported by established links to a group of Toronto academic research institutes and cancer treatment centers, representing one of the world's most acclaimed cancer research hubs. SCT's clinical stage programs include the recently in-licensed program focused on the structure of tigecycline, which is currently being evaluated in a multi-centre Phase I study in patients with acute myeloid leukemia (AML), as well as TTI-1612, a non-stem cell asset being tested in a 28-patient Phase I trial in interstitial cystitis ("IC") patients, which is near completion. The Company also has two premier preclinical programs, SIRPaFc and a CD200 monoclonal antibody (mAb), which target two key immunoregulatory pathways that tumor cells exploit to evade the host immune system. SIRPaFc is an antibody-like fusion protein that blocks the activity of CD47, a molecule that … Continue reading →

Posted in Stem Cell Research | Comments Off on Stem Cell Therapeutics Provides Corporate Update

Henry R. Kranzler, MD, Named Director of Penn's Center for Studies of Addition

Posted: Published on July 26th, 2013

Newswise PHILADELPHIAHenry R. Kranzler, MD, a professor of Psychiatry at the Perelman School of Medicine at the University of Pennsylvania whose work has contributed to the identification of genetic risk factors and pharmacological treatments for drug and alcohol dependence, has been named the Director of the Center for Studies of Addiction. Dr. Kranzler received his medical degree from Robert Wood Johnson Medical School and completed a psychiatric residency and a fellowship in alcohol research at the University of Connecticut Health Center. He came to Penn Medicine in 2010 after a lengthy career at the University of Connecticut, where he was an Associate Scientific Director of the Alcohol Research Center, Program Director of the Lowell P. Weicker General Clinical Research Center, and Associate Dean for Clinical and Translational Research. Since 1987, Dr. Kranzlers research has been funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and National Institute on Drug Abuse (NIDA). His contributions to the field of alcohol research include advancing clinical trials methodology as it relates to pharmacological treatment, the identification of interactive effects of serotonergic medications with alcoholism subtypes, the use of a targeted approach to naltrexone treatment of heavy drinkers, and the development of long-acting … Continue reading →

Comments Off on Henry R. Kranzler, MD, Named Director of Penn's Center for Studies of Addition

Single Genetic Glitch May Explain Most Allergies and Asthma

Posted: Published on July 26th, 2013

Home Mail News Sports Finance Weather Games Groups Answers Flickr More omg! Shine Movies Music TV Health Shopping Travel Autos Homes Search News Search Web Sign In Mail Help Account Info Help Suggestions Yahoo! Home Video Photos GMA Year in Review LiveRoom Odd Comics Travel Opinion Trending Now Who Knew? Weather The Upbeat U.S. U.S. Video GMA Education Religion Crimes and Trials The Lookout Local Contributor Network Year In Review World World Video Middle East Europe Latin America Africa Asia Canada Australia/Antarctica Business Video Exclusives Today's Markets Stocks Personal Finance Marketplace Entertainment Video Clinton Concert Celebrity TV Movies Music Fashion Books Arts Theater Dear Abby Comics Odd News Sports Video NFL MLB NBA NCAAF NCAAB Soccer Cycling NHL Tennis Golf Boxing Motor Sports MMA Olympics Tech Gadgets Wireless Apple Social Media Security Open Source Gaming Apps This Could Be Big Upgrade Your Life Politics Remake America The Issues Women and Politics Press Releases Video Science Science Video Weather News Space / Astronomy Pets Dinosaurs / Fossils Biotech Energy Green Health Video Weight Loss Cancer Sexual Health Medications/Drugs Parenting/Kids Seniors/Aging Diseases/Conditions Blogs The Lookout The Sideshow Around the World Katie's Take Power Players This Could Be Big Newsmakers Trending Now Just … Continue reading →

Comments Off on Single Genetic Glitch May Explain Most Allergies and Asthma

Study of Genetic Condition May Yield Clues to Cause of Allergies

Posted: Published on July 26th, 2013

By Dennis Thompson HealthDay Reporter WEDNESDAY, July 24 (HealthDay News) -- A disorder that affects connective tissue could provide vital clues to the genetic origin of nearly all human allergies and allergic diseases, say the authors of a new study of children. People who have Loeys-Dietz syndrome tend to also suffer disproportionately from allergic diseases, researchers at Johns Hopkins Children's Center and the Johns Hopkins Institute of Genetic Medicine in Baltimore found when looking at a group of 58 children aged 7 to 20 who have the syndrome. "We found that these patients had a very high risk of developing not just one allergy, but all forms of allergic disease," said study author and immunologist Dr. Pamela Frischmeyer-Guerrerio. In their paper, published July 24 in Science Translational Medicine, the researchers contend that the genetic mutation that causes Loeys-Dietz syndrome appears to be closely tied to allergies -- so much so that it might explain why certain people suffer from allergic reactions. However, other allergists are skeptical, saying the genetic link could just be a coincidence. Loeys-Dietz syndrome is caused by the mutation of a gene called TGFb, and the researchers wondered if this mutation also might create a greater susceptibility … Continue reading →

Comments Off on Study of Genetic Condition May Yield Clues to Cause of Allergies

LifeMap Sciences Announces Release of LifeMap Discovery™ Version 1.2 With Extensive Stem Cell Therapy Data

Posted: Published on July 26th, 2013

ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc. announced today the release of LifeMap Discovery version 1.2 (discovery.lifemapsc.com). LifeMap Discovery is a state-of-the-art roadmap of embryonic development and stem cell biology. The product integrates embryonic development and stem cell biology, molecular, cellular, anatomical, and disease-related information, and provides data-mining capabilities and bioinformatics applications. As such, it is a unique and powerful tool for research and discovery in multiple disciplines, including stem cell biology, developmental biology and disease mechanisms and etiology. LifeMap Discovery version 1.2 provides enhanced features related to stem cell therapeutic development LifeMap Discovery is a key component in LifeMaps integrated database suite, a discovery platform for biomedical and stem cell research, which also includes GeneCards, the leading human gene database, and MalaCards, the human disease database. LifeMap Discovery version 1.2 new features and information include the following: LifeMap Discovery version 1.2 provides enhanced features related to stem cell therapeutic development, said Ronit Shtrichman, Ph.D., MBA, Vice President of Biology at LifeMap Sciences. This version includes substantially upgraded information about stem cells with potential therapeutic applications and stem cell differentiation protocols. It also enables researchers to identify genes specifically expressed during embryonic development and stem cells differentiation, providing the means to generate … Continue reading →

Comments Off on LifeMap Sciences Announces Release of LifeMap Discovery™ Version 1.2 With Extensive Stem Cell Therapy Data

Has Mariusz Ratajczak Found the Holy Grail of Stem Cells?

Posted: Published on July 26th, 2013

Home Mail News Sports Finance Weather Games Groups Answers Flickr More omg! Shine Movies Music TV Health Shopping Travel Autos Homes Search News Search Web Sign In Mail Help Account Info Help Suggestions Yahoo! Home Video Photos GMA Year in Review LiveRoom Odd Comics Travel Opinion Trending Now Who Knew? Weather The Upbeat U.S. U.S. Video GMA Education Religion Crimes and Trials The Lookout Local Contributor Network Year In Review World World Video Middle East Europe Latin America Africa Asia Canada Australia/Antarctica Business Video Exclusives Today's Markets Stocks Personal Finance Marketplace Entertainment Video Clinton Concert Celebrity TV Movies Music Fashion Books Arts Theater Dear Abby Comics Odd News Sports Video NFL MLB NBA NCAAF NCAAB Soccer Cycling NHL Tennis Golf Boxing Motor Sports MMA Olympics Tech Gadgets Wireless Apple Social Media Security Open Source Gaming Apps This Could Be Big Upgrade Your Life Politics Remake America The Issues Women and Politics Press Releases Video Science Science Video Weather News Space / Astronomy Pets Dinosaurs / Fossils Biotech Energy Green Health Video Weight Loss Cancer Sexual Health Medications/Drugs Parenting/Kids Seniors/Aging Diseases/Conditions Blogs The Lookout The Sideshow Around the World Katie's Take Power Players This Could Be Big Newsmakers Trending Now Just … Continue reading →

Comments Off on Has Mariusz Ratajczak Found the Holy Grail of Stem Cells?

Page 5,024«..1020..5,0235,0245,0255,026..5,0305,040..»